Antidepressant-like behavioral effects of impaired cannabinoid receptor type 1 signaling coincide with exaggerated corticosterone secretion in mice

This publication has 43 references indexed in Scilit:

• Impaired cannabinoid receptor type 1 signaling interferes with stress-coping behavior in mice
  The Pharmacogenomics Journal, 2007
• A therapeutic role for cannabinoid CB1 receptor antagonists in major depressive disorders
  Trends in Pharmacological Sciences, 2005
• The ascent of mouse: advances in modelling human depression and anxiety
  Nature Reviews Drug Discovery, 2005
• Is there a role for the endocannabinoid system in the etiology and treatment of melancholic depression?
  Behavioural Pharmacology, 2005
• Stress and the brain: from adaptation to disease
  Nature Reviews Neuroscience, 2005
• The role of endogenous cannabinoids in the hypothalamo-pituitary-adrenal axis regulation: in vivo and in vitro studies in CB1 receptor knockout mice
  Life Sciences, 2004
• Context‐dependent effects of CB1 cannabinoid gene disruption on anxiety‐like and social behaviour in mice
  European Journal of Neuroscience, 2004
• Endogenous cannabinoid system as a modulator of food intake
  International Journal of Obesity, 2003
• The effects of genetic and pharmacological blockade of the CB1 cannabinoid receptor on anxiety
  European Journal of Neuroscience, 2002
• The Corticosteroid Receptor Hypothesis of Depression
  Neuropsychopharmacology, 2000